Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03694613 · ClinicalTrials.gov registry record · NA
Utility of Placental/Umbilical Cord Blood in Early Onset Neonatal Sepsis in Very Low Birth Weight Infants
A NA study, sponsored by The University of Texas Medical Branch, Galveston.
- Completed
- Registry status
- NA
- Development phase
- 65
- Enrollment target
NCT03694613 is a NA study that has completed, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 65 participants.
The verdict
NCT03694613, a NA study, has completed, sponsored by The University of Texas Medical Branch, Galveston.
- COMPLETED
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
Study Summary
This study evaluates the utility of placental/umbilical cord blood (PUCB) to perform the baseline workup testing for EONS in Very Low Birth Weight Infants: CBC (Complete Blood Count) with differential, Immature/Total ratio (I/T ratio), and blood culture along with CRP and IL-6 levels. A cohort (63 subjects) of preterm infants will be recruited. All the participants will be evaluated for sepsis using placental/umbilical cord blood (PUCB) and subject blood sample during the first 12 hours of life (after birth).
Interventions
- OTHER Placental/Umbilical Cord Blood sample
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2019-06-01 |
| Est. Completion | 2020-08-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03694613
The ClinicalTrials.gov registry entry for NCT03694613 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Medical Branch, Galveston, which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Placental/Umbilical Cord Blood sample is the first listed.
NCT03694613 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03694613 about?
NCT03694613 is a clinical study titled "Utility of Placental/Umbilical Cord Blood in Early Onset Neonatal Sepsis in Very Low Birth Weight Infants". This study evaluates the utility of placental/umbilical cord blood (PUCB) to perform the baseline workup testing for EONS in Very Low Birth Weight Infants: CBC (Complete Blood Count) with differential, Immature/Total ratio (I/T ratio), and blood culture along with CRP and IL-6 levels. A cohort (63 s...
What is the current status of trial NCT03694613?
This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2019-06-01. Estimated completion is 2020-08-20.
What interventions are being tested in trial NCT03694613?
The interventions under investigation include: Placental/Umbilical Cord Blood sample (OTHER).
Who is sponsoring clinical trial NCT03694613?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.